SCHEMBL8874121

SCHEMBL8874121

CC(C)(C)C[C@H](O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4135528 1.00
SCHEMBL2163787 0.81 TSHR (0.35)
SCHEMBL29512386 0.80 GABRR1 (0.36)
SCHEMBL5138836 0.80
SCHEMBL1132105 0.80
SCHEMBL20656259 0.78
SCHEMBL28117175 0.78 GABBR2 (0.32)
SCHEMBL1132763 0.76 GABRR1 (0.33)
SCHEMBL502445 0.76 GABRR1 (0.33)
SCHEMBL13071622 0.75 TSHR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212148-A1 THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION GILEAD SCIENCES, INC. 2023-07-06 US disclosed
US-5670652-A REACTION OF NEOPENTYLGLYCINOL WITH CHLOROFORMIC ACID TO FORM ALKYLOXAZOLIDINONE DEGUSSA AKTIENGESELLSCHAFT (DE) 1997-09-23 US disclosed
EP-0692478-A1 Process for the preparation of optically active 4 substituted (S)-2-oxazolidinone, optically active (S)-aminoalcohols and utilization of there compounds Degussa Aktiengesellschaft (DE) 1996-01-17 EP disclosed
EP-0692538-A2 Process for producing optically active L-amino acids, novel optically active L-aminoacids with bulky side-chains and their use Degussa Aktiengesellschaft (DE) 1996-01-17 EP disclosed